Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis

Journal of Nuclear Cardiology - 2014
Michael T. Osborne1, Edward Hulten2, Avinainder Singh3, Alfonso H. Waller2, Márcio Bittencourt2, Garrick C. Stewart4, Jon Hainer2, Venkatesh L. Murthy5, Hicham Skali2, Sharmila Dorbala2, Marcelo F. Di Carli2, Ron Blankstein2
1Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
2Non-Invasive Cardiovascular Imaging Program, Department of Medicine (Cardiovascular Division) and Department of Radiology, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA, 02115, USA
3Government Medical College and Hospital, Chandigarh, India
4Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA
5Departments of Internal Medicine and Radiology, University of Michigan, Ann Arbor, MI, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Iannuzzi, 2011, Sarcoidosis: Clinical presentation, immunopathogenesis, and therapeutics, J Am Med Assoc, 305, 391, 10.1001/jama.2011.10

Silverman, 1978, Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis, Circulation, 58, 1204, 10.1161/01.CIR.58.6.1204

Yazaki, 2001, Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone, Am J Cardiol, 88, 1006, 10.1016/S0002-9149(01)01978-6

Schliamser, 2013, Significance of follow-up left ventricular ejection fraction measurements in the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation trial (DEFINITE), Heart Rhythm, 10, 838, 10.1016/j.hrthm.2013.02.017

Chiu, 2005, Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis, Am J Cardiol, 95, 143, 10.1016/j.amjcard.2004.08.083

Grutters, 2006, Corticosteroid treatment in sarcoidosis, Eur Respir J, 28, 627, 10.1183/09031936.06.00105805

Nery, 2012, Arrhythmias in cardiac sarcoidosis: Diagnosis and treatment, Curr Opin Cardiol, 27, 181, 10.1097/HCO.0b013e32834e4c7c

Youssef, 2011, Cardiac sarcoidosis: Applications of imaging in diagnosis and directing treatment, Heart, 97, 2078, 10.1136/hrt.2011.226076

Blankstein, 2013, Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis, J Am Coll Cardiol

Okumura, 2004, Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis, J Nucl Med, 45, 1989

Ohira, 2011, (1)F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis, Eur J Nucl Med Mol Imaging, 38, 1773, 10.1007/s00259-011-1832-y

Dorbala, 2007, Value of vasodilator left ventricular ejection fraction reserve in evaluating the magnitude of myocardium at risk and the extent of angiographic coronary artery disease: A 82Rb PET/CT study, J Nucl Med, 48, 349

Kida, 2013, Late gadolinium enhancement on cardiac magnetic resonance images predicts reverse remodeling in patients with nonischemic cardiomyopathy treated with carvedilol, Int J Cardiol, 168, 1588, 10.1016/j.ijcard.2013.01.043

Lower, 1995, Prolonged use of methotrexate for sarcoidosis, Arch Intern Med, 155, 846, 10.1001/archinte.1995.00430080088011

Schuller, 2012, Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis, J Cardiovasc Electrophysiol, 23, 925, 10.1111/j.1540-8167.2012.02350.x

Betensky, 2012, Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators, Heart Rhythm, 9, 884, 10.1016/j.hrthm.2012.02.010

Boellaard, 2011, Need for standardization of 18F-FDG PET/CT for treatment response assessments, J Nucl Med, 52, 93S, 10.2967/jnumed.110.085662

Boellaard, 2009, Standards for PET image acquisition and quantitative data analysis, J Nucl Med, 50, 11S, 10.2967/jnumed.108.057182

Thông tin
Thông tin xuất bản

Journal of Nuclear Cardiology

Thông tin tác giả